Standout Papers
- Human papillomavirus and cervical cancer (2007)
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer (2012)
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice (2005)
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer (2012)
- 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors (2020)
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer (2012)
- Human Papillomavirus Testing in the Prevention of Cervical Cancer (2011)
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older (2008)
- Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses (2018)
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice (2011)
- Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study (2011)
- Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study (2019)
Immediate Impact
6 by Nobel laureates 17 from Science/Nature 109 standout
Citing Papers
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cervical cancer screening using DNA methylation triage in a real-world population
2024 Standout
Works of Philip E. Castle being referenced
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
2020 Standout
Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Philip E. Castle | 20692 | 8960 | 6299 | 339 | 23.8k | |
| Rolando Herrero | 22632 | 11619 | 5598 | 344 | 30.0k | |
| Keerti V. Shah | 17349 | 8194 | 5995 | 184 | 23.4k | |
| Joakim Dillner | 19800 | 7962 | 7281 | 566 | 27.1k | |
| Nicolas Wentzensen | 15848 | 7520 | 6560 | 370 | 23.4k | |
| Núbia Muñóz | 21110 | 12321 | 5722 | 218 | 29.9k | |
| Mark Schiffman | 30890 | 13837 | 8008 | 424 | 36.3k | |
| Allan Hildesheim | 14193 | 6480 | 5324 | 332 | 22.0k | |
| Robert D. Burk | 22138 | 9895 | 4948 | 471 | 30.5k | |
| Xavier Castellsagué | 15675 | 8274 | 3756 | 141 | 20.7k | |
| Jennifer S. Smith | 14771 | 6857 | 3385 | 333 | 18.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...